Oxford PharmaGenesis

Oxford PharmaGenesis combines consulting and services across medical affairs, market access, value demonstration, HEOR, real-world evidence, and product launch planning. Its work spans evidence strategy, scientific communications, payer materials, and training, and a dedicated health policy team delivers evidence-based policy initiatives.

Medical Affairs and Scientific Communications

• Shape medical affairs strategies through planning, scientific narrative and communications platform development, and evidence gap assessment.
• Run advisory boards and councils, including patient and caregiver partnership groups, patient advisory involvement in Delphi panels, and expert advisory activities.
• Create medical communications, scientific publications, plain language summaries and related materials, with publication planning and communication strategy support.
• Prepare congress materials and extend scientific dissemination through poster-hosting, video abstracts, plain language summaries, animations, webinars and graphical abstracts.

Evidence, Access and Value Demonstration

• Plan integrated evidence programs across clinical, real-world and HEOR needs, using workshops and strategic consultancy to develop coordinated plans.
• Assess payer landscapes and access needs by gathering and structuring published and unpublished evidence to inform market access strategies.
• Develop and report HEOR studies, including evidence syntheses, systematic literature reviews, real-world studies, patient-reported outcomes, indirect treatment comparisons and health economic models, for HTA, value dossiers, publications and related outputs.
• Support HTA and joint clinical assessment activities through access strategy, advisory workshops, submission drafting, modelling, negotiation preparation and post-submission work.

Market Access and Payer Communication

• Build market access and launch plans by combining input from payers, policymakers, clinicians, health economists and patients with evidence planning.
• Create payer-facing value dossiers, value story decks and objection handlers that explain complex analyses and the implications of product uptake for patients and healthcare systems.
• Support payer communication with evidence-based tools, including interactive economic models and animations of indirect treatment comparison methodology.

Launch and Capability Building

• Support product launches with launch strategy and readiness planning.
• Develop training and enablement programs, including bespoke self-directed and live learning for HEOR, real-world evidence and market access topics.
• Support real-world evidence programs through planning, generation, communications strategy and coordination, and assessment of real-world data sources, with experience spanning registries and health system database studies.

Best Fit

• Pharmaceutical and life-sciences teams planning evidence, access, HTA or payer communication programs that require strategic consultancy and practical scientific outputs.
• Medical affairs, HEOR, market access and launch teams needing coordinated support across evidence planning, publications, advisory activities, congress communication and training.